WithdrawnNot Applicable

Application of Group Interpersonal Psychotherapy (IPT-G) to Family Members Caring for Patients With Schizophrenia

Stopped: People didn't apply. The number of participants required to begin the intervention was not reached.

Turkey (Türkiye)0Started 2024-07

Plain-language summary

The goal of this re-measured quasi-experimental study is to evaluate the effect of Group Interpersonal Psychotherapy (IPT-G) intervention given to caregiver family members of people with schizophrenia on caregiver burden, perception of social support and stigma, adherence to treatment in people with schizophrenia they care for, and emotional expression in both caregivers and people with schizophrenia they care for. The main hypotheses it aims to test are: 1. IPT-G intervention will reduce the caregiver burden of caregivers of individuals with schizophrenia. 2. IPT-G intervention will increase the perceived social support levels of caregivers of individuals with schizophrenia. 3. IPT-G intervention will reduce the level of stigma of caregivers of individuals with schizophrenia. 4. IPT-G intervention will reduce the level of emotional expression of caregivers of individuals with schizophrenia. 5. IPT-G intervention applied to caregivers will increase the level of adherence to treatment of individuals with schizophrenia they care for. 6. IPT-G intervention applied to caregivers will reduce the emotional expression levels of individuals with schizophrenia they care for.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Be between the ages of 18-65 * Being able to speak and understand fluent Turkish, * Being the primary caregiver of a family member with one of the Schizophrenic Disorders and Psychotic Disorders, * Caring for a family member with Schizophrenia and Schizophrenia Spectrum Disorder for at least 6 months. * Both the caregiver and the patient voluntarily agree to participate in the study. Exclusion Criteria: * Having a dismissive attachment style (to be evaluated by the researcher), * Having antisocial personality traits (to be evaluated by the researcher), * Having narcissistic personality traits (to be evaluated by the researcher), * Having active suicidal ideation (to be evaluated by the investigator). Removal criteria: * Not attending more than two sessions of the 7-session intensive/group phase * Failure to comply with the norms and rules of group therapy (continuity, confidentiality, respectful communication, interaction with group members, participation)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in caregiver burden evaluated with the Zarit Caregiver Burden Scale (ZCBS)

Timeframe: Change in caregiver burden at 6 months

Trial details

NCT IDNCT05870384

SponsorAbant Izzet Baysal University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10

View on ClinicalTrials.gov More Interpersonal Psychotherapy trials